2016 Spinning Capacity of Texhong Group Reach 2.89 Million Spindles
For the year ended 31 December 2016, the revenue of the Texhong Group, with total annual production capacity of about 2.89 million spindles, 816 looms and 18 denim production lines, reached a record high of RMB13.65 billion, representing an increase of 29.1% y-o-y, principally driven by the growth in the sales volume of yarn.
Revenue of the Group comprises sales of yarn, grey fabric and garment fabrics as well as garments. During the year, yarn continued to be the major product of the Group, accounting for 92.5% of the Group’s total revenue for the year, amounting to RMB12.63 billion and representing an increase of 28.4% on the year. New capacity of approximately 630,000 spindles from the production plants of the Galaxy project in Vietnam and the Xinjiang project commenced full production successively in 2016. For the year ended 31 December 2016, driven by the expansion of production, the Group’s yarn sales volume increased by 25.7% to a historical high of about 600,000 tonnes when compared to last year.
2026-09-16
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Asahi Kasei Expands Planova Production with New Spinning Plant
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
Recommend Reading
-
Trump Urges Ukraine to Halt Russian Refinery Strikes as Diesel Shortage Becomes a Global Policy Issue
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
FDA Warning Letters Put GMP Back in Focus
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
Butadiene Rubber Market Prices Drop Sharply
-
Formic Acid Market Supply Is Loose, Inventory Reduction Is Orderly
-
Cost-side support weakens, PTA price center of gravity continues to shift downward
-
Business Society’s MTBE Market Outlook on August 24, 2026: Continuing to Rise
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 24, 2026: Volatile